Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/03/2004CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004CN1173745C Use of chemically modified methioninase in anti-methionine and anti-homocysteine chemotherapy
11/03/2004CN1173738C Utilization of interferon alpha 5 in the preparation of drugs for viral hepatopathies
11/03/2004CN1173710C Treatment of congestive heart failure by pretreated autologous blood
11/02/2004US6812379 Expression of eukaryotic peptides in plant plastids
11/02/2004US6812377 Enzymatic polypeptide; for use in paper making
11/02/2004US6812338 Polypeptide for use in generating transgenic heat resistant plants
11/02/2004US6812335 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
11/02/2004US6812037 Antimitotic compounds
11/02/2004US6812027 Therapy for brain disorders
11/02/2004US6812026 Antibodies directed against binding-associated epitopes
11/02/2004US6812023 Methods of producing membrane vesicles
11/02/2004US6812021 Isolated from streptococcus; for preparation of therapeutics (vaccines) to immunize against microbial infection; urinary tract infections; drug screening
11/02/2004US6812014 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof
11/02/2004US6811981 Release of intracellular material
11/02/2004US6811972 For preparing a hybridoma cell line which specifically recognizes and binds tumor associated antigen; antibodies; prostate carcinoma tumor antigen gene-1
11/02/2004US6811777 Compositions and minimally invasive methods for treating incomplete connective tissue repair
11/02/2004US6811776 Process for ex vivo formation of mammalian bone and uses thereof
11/02/2004US6811774 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
11/02/2004CA2283676C Stimulation, culture and preservation of pancreatic and other cells
11/02/2004CA2220715C Functional bioassay for g-protein coupled receptor agonists and antagonists
10/2004
10/28/2004WO2004092726A1 Ex vivo skin organ model made of pig skin
10/28/2004WO2004092397A2 Tmprss2 regulatory sequences and uses thereof
10/28/2004WO2004092359A1 Process for producing cartilage cells for transplantation
10/28/2004WO2004092358A1 Implement and method for freezing and storing egg
10/28/2004WO2004092357A1 Method of growing sperm stem cells in vitro, sperm stem cells grown by the method, and medium additive kit to be used in growing sperm stem cells in vitro
10/28/2004WO2004092356A2 Method for obtaining mastocyte lines from porcine tissue and method for production of heparin type molecules
10/28/2004WO2004092355A1 Expression of proteins in cord blood-derived endothelial cells
10/28/2004WO2004092354A2 Ex vivo skin organ model, especially for human skin
10/28/2004WO2004092348A2 Method for production of oncolytic adenoviruses
10/28/2004WO2004092322A2 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
10/28/2004WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004WO2004091678A1 Chitosan film used as a periosteum replacement
10/28/2004WO2004091637A2 System capable of treating and defining various diseases using stem cells
10/28/2004WO2004091525A2 Morpholino imaging and therapy via amplification targeting
10/28/2004WO2004091495A2 Compositions and methods related to production of erythropoietin
10/28/2004WO2004083375A3 Methods of promoting the differentiation of stem cells
10/28/2004WO2004081205A8 Differentiation of human embryonic stem cells to cardiomyocytes
10/28/2004WO2004078915A3 Cell culture
10/28/2004WO2004074439A3 An expression cassette and vector for transient or stable expression of exogenous molecules
10/28/2004WO2004072251A9 Directed genetic modifications of human stem cells
10/28/2004WO2004060145A3 Isolation and identification of cross-reactive t cells
10/28/2004WO2004053057A3 Gene expression systems and recombinant cell lines
10/28/2004WO2004043386A3 Molecules preferentially associated with effector t cells and methods of their use
10/28/2004WO2004035748A3 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells
10/28/2004WO2004018660A3 Novel lipases and uses thereof
10/28/2004WO2004009777A3 Compositions and methods to select dendritic cells from a heterogeneous cell population
10/28/2004WO2004003176A3 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
10/28/2004WO2004003157A3 Gene regulation in transgenic animals using a transposon-based vector
10/28/2004WO2003100005A3 Universal chimera bank
10/28/2004WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004WO2003074007A3 Modulators of leukocyte activation, compositions, and methods of use
10/28/2004WO2003070908A3 Novel spinosyn-producing polyketide synthases
10/28/2004WO2003052064A3 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
10/28/2004WO2003044169A3 Compositions and methods for reversibly inducing continual growth in normal cells
10/28/2004WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004WO2003022125A3 Device and method to maintain vascularization near implant
10/28/2004WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004US20040216180 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same
10/28/2004US20040216179 Recombinant plasmid expressing two fluorescence genes
10/28/2004US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004US20040214997 includes growth factors and extracellular matrix molecules flexibly tethered to a support medium; used to stimulate cell and tissue growth by enhancment of the biological response to the growth factor; liver cells
10/28/2004US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004US20040214777 Peptide activators of VEGF
10/28/2004US20040214773 Methods and compositions for the inhibition of cathepsins
10/28/2004US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004US20040214333 Loading of cells with antigens by electroporation
10/28/2004US20040214332 Stable, multipotent transgenic nervous system progenitor tissue for treatment and prevention of neurodegenerative disorders
10/28/2004US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004US20040214329 Circular nucleic acid vectors, and methods for making and using the same
10/28/2004US20040214327 Nutrient broth comprising transition element ptoyrin complex complex for use in cell propagation
10/28/2004US20040214326 Bandage for enhancing tissue repair and growth; prosthetics; tissue engineering
10/28/2004US20040214324 Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases
10/28/2004US20040214323 Long lived keratinocytes
10/28/2004US20040214322 PLGA substrate with aligned and nano-sized surface structures and associated method
10/28/2004US20040214321 Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
10/28/2004US20040214320 Nutrient broth comprising recombinant human albumin, fermented hyaluronan and citrate for enhancing viability of propagating germ cells
10/28/2004US20040214319 Using lysophospholipid G-protein coupled receptor (LPL) to initiate spontaneous differentiation of progenitor cells; for use in functional genomics, growth factor and drug discovery, toxicology and cell transplantation
10/28/2004US20040214290 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
10/28/2004US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004US20040214275 Von willebrand factor (vmf)-cleaving enzyme
10/28/2004US20040214273 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/28/2004US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004US20040214247 Comprises immunoglobulin which binds to tumor specific epitope and inhibits binding of matrix protein/collagen/gelatin complexes; immunotherapy and antitumor agents
10/28/2004US20040214241 Enhancing culture for osteoblast using immunomagnetic separation; treating osteoporosis
10/28/2004US20040214239 Functional coupling of T1Rs and T2Rs by GI proteins, and cell-based assays for the identification of T1R and T2R modulators
10/28/2004US20040214238 Nociceptive neuron specific calcium channel isoform and uses thereof
10/28/2004US20040214234 Method
10/28/2004US20040214230 Monoclonal antibody which binds galanin-lke peptides for use in diagnosis, prevention and treatment of obesity, sterility, collagen or rheumatic disease
10/28/2004US20040214226 Method of screening candidate compounds for susceptibility to biliary excretion by endogenous transport systems